TC
RIGL icon

Truvestments Capital’s Rigel Pharmaceuticals RIGL Stock Holding History

Truvestments Capital’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.7K Hold
2,207
– – 0.01% 474
2025
Q4 		$94.5K Buy
2,207
+1,205
+120% +$45.4K 0.02% 347
2025
Q3 		$28.4K Buy
1,002
+125
+14% +$3.74K 0.01% 531
2025
Q2 		$16.4K Buy
+877
New +$16.6K ﹤0.01% 572

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Truvestments Capital's RIGL Position: Q1 2026 in Review

Truvestments Capital held its Rigel Pharmaceuticals (RIGL) position steady in Q1 2026 at 2,207 shares worth $59.7K. The position accounts for 0.01% of the portfolio, ranked #474.

Truvestments Capital first reported a position in RIGL in Q2 2025 and has held it in 4 quarters since. The position peaked at $94.5K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Truvestments Capital held 2,207 shares of Rigel Pharmaceuticals worth $59.7K as of Q1 2026.
  • Truvestments Capital left its Rigel Pharmaceuticals share count unchanged in Q1 2026.
  • Rigel Pharmaceuticals made up 0.01% of Truvestments Capital's portfolio in Q1 2026, its #474 holding.
  • Truvestments Capital first reported a position in Rigel Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Truvestments Capital's Rigel Pharmaceuticals position peaked at $94.5K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.